Location · Oklahoma City, OK
Clinical trials in Oklahoma City, OK
171 recruiting studies have a site in the Oklahoma City area, and 32 of them accept healthy volunteers. The area includes Edmond, Norman, Moore, Midwest City, Yukon and nearby cities.
171 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Huntsville, AL + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Birmingham, AL + 69 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ansun Biopharma, Inc.
- Location
- Duarte, CA + 18 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
AbbVie
- Location
- Huntsville, AL + 46 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Pfizer
- Location
- Little Rock, AR + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Urovant Sciences GmbH
- Location
- Little Rock, AR + 6 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
ModernaTX, Inc.
- Location
- Farmington Hills, MI + 5 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 2
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
AbbVie
- Location
- Dothan, AL + 32 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Phoenix, AZ + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Travoprost Intraocular Implant + iStent Infinite
Glaukos Corporation
- Location
- Oklahoma City, OK
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Fate Therapeutics
- Location
- Beverly Hills, CA + 15 other US sites
- Eligibility basics
- Ages 12–70
- RecruitingPhase 2
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Rivus Pharmaceuticals, Inc.
- Location
- Chandler, AZ + 30 other US sites
- Eligibility basics
- Ages 30+
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Los Angeles, CA + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
argenx
- Location
- Phoenix, AZ + 16 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SELUTION4BTK Trial
M.A. Med Alliance S.A.
- Location
- Chandler, AZ + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)
Noveome Biotherapeutics, formerly Stemnion
- Location
- Little Rock, AR + 7 other US sites
- Eligibility basics
- Ages 0 mo–2 mo
- RecruitingPhase 2
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited
- Location
- Little Rock, AR + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Vanda Pharmaceuticals
- Location
- Tempe, AZ + 17 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
BioVentrix
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Los Angeles, CA + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 2
Open-label Extension Study in Participants With Early Alzheimer's Disease
GlaxoSmithKline
- Location
- Maitland, FL + 8 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 2
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Autobahn Therapeutics, Inc.
- Location
- Birmingham, AL + 31 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
Pacira Pharmaceuticals, Inc
- Location
- Indianapolis, IN + 4 other US sites
- Eligibility basics
- Ages 0 mo–6
- RecruitingPhase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited
- Location
- Birmingham, AL + 11 other US sites
- Eligibility basics
- Ages 40+